REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 57 filers reported holding REPLIMUNE GROUP INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $48,858,000 | -9.1% | 2,122,415 | -1.9% | 4.55% | -19.1% |
| Q2 2020 | $53,741,000 | +89.9% | 2,162,598 | -23.8% | 5.63% | +17.6% |
| Q1 2020 | $28,305,000 | -30.5% | 2,838,968 | 0.0% | 4.79% | -21.2% |
| Q4 2019 | $40,739,000 | +3.2% | 2,838,968 | 0.0% | 6.08% | -40.2% |
| Q3 2019 | $39,462,000 | -5.2% | 2,838,968 | 0.0% | 10.16% | -51.9% |
| Q2 2019 | $41,619,000 | -3.7% | 2,838,968 | 0.0% | 21.14% | +22.4% |
| Q1 2019 | $43,209,000 | +52.2% | 2,838,968 | 0.0% | 17.28% | +78.1% |
| Q4 2018 | $28,390,000 | -37.9% | 2,838,968 | 0.0% | 9.70% | -6.5% |
| Q3 2018 | $45,707,000 | – | 2,838,968 | – | 10.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,103,455 | $82,166,000 | 38.87% |
| Bain Capital Life Sciences Investors, LLC | 2,838,968 | $45,707,000 | 10.37% |
| Foresite Capital Management IV, LLC | 1,229,656 | $19,797,000 | 6.49% |
| Foresite Capital Management III, LLC | 779,656 | $12,552,000 | 2.77% |
| BVF INC/IL | 911,852 | $14,681,000 | 1.29% |
| Redmile Group, LLC | 2,192,957 | $35,307,000 | 1.09% |
| Cormorant Asset Management, LP | 467,792 | $7,531,000 | 0.49% |
| DC Investments Management, LLC | 39,578 | $637,000 | 0.43% |
| EMERALD ADVISERS, LLC | 618,080 | $9,951,000 | 0.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 523,316 | $8,425,000 | 0.28% |